Načítá se...
The use of targeted therapies and selection of the optimal treatment sequence in heterogeneous population of patients with metastatic kidney cancer. Results of retrospective study
Renal cancer is one of the most rapidly spreading diseases in the world. As you know, a few years ago, overall survival of patients with metastatic renal cell carcinoma (mRCC) was disappointing: median overall survival rarely exceeded 13 months, while 5-year survival rate was less than 5 %. Immunoth...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
ABV-press
2016-09-01
|
| Edice: | Onkourologiâ |
| Témata: | |
| On-line přístup: | https://oncourology.abvpress.ru/oncur/article/view/608 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|